Citius Oncology Inc

CTOR12 Dec 2024
Healthcare
$1.17
+0.04 (+3.64%)
Lowest Today
$1.08
Highest Today
$1.17
Today’s Open
$1.17
Prev. Close
$1.1
52 Week High
$40.5
52 Week Low
$0.85
BUY
SELL
To Invest in Citius Oncology Inc

Citius Oncology Inc

Healthcare
CTOR12 Dec 2024
₹
+0.04 (+3.64%)
1M
3M
6M
1Y
5Y
Low
$1.08
Day’s Range
High
$1.17
1.08
52 Week Low
$0.85
52-Week Range
52 Week High
$40.5
0.85
1 Day
-
1 Week
-20%
1 month return
-18.24%
3 month return
-33.33%
6 month return
-97.33%
1 Year return
-
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
116.23 mln
PB Ratio
4.55
PE Ratio
0
Enterprise Value
116.23 mln
Total Assets
47.73 mln
Volume

Fund house & investment objective

Company Information
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc.  operates as a subsidiary of Citius Pharmaceuticals, Inc.
Organisation
Citius Oncology Inc
Employees
0
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Leonard L. Mazur
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Get expert assistance for portfolio management

BUY
SELL